XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation® Technology Kumar Jeetendra | October 22, 2020 SAN DIEGO, U.S.A., and FREISING, Germany, October 15, 2020 – Life Science Newswire – Antlia Bioscience, Inc., a privately owned biopharmaceutical company located in San Diego, California, and XL-protein GmbH, a privately owned biopharmaceutical company located in Germany, are pleased to announce a strategic slliance using XL-protein’s proprietary PASylation® technology for plasma half-life extension to …
Cipla secures a spot among the top global employers in Forbes’ “World’s Best Employers 2021” list Kumar Jeetendra | October 15, 2021 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) has emerged as the only Indian pharma company to secure a spot in the Forbes “World’s Best Employers 2021” list among the top global employers across 58 countries. Cipla also features as the sole Indian player being featured as a part of …
Indian vaccine makers have great potential in regulated markets: Mr. Aditya Sharma,Merck Life Science India Kumar Jeetendra | October 3, 2022 In this article, Microbioz India is pleased to share an exclusive interview with Mr. Aditya Sharma, Head of BioProcess business for the India Region – Merck Life Science Could you go into more detail about the motivation for creating the MLab and its journey so far? Life science is a sunrise segment in India. Over …
